| 孙健,朴惠顺,李英姬.对药品GMP质量管理体系中变更控制、偏差管理、质量风险管理的探讨[J].中国药事,2018,32(1):88-91 |
| 对药品GMP质量管理体系中变更控制、偏差管理、质量风险管理的探讨 |
| On Alternation Control Deviation Management and Quality Risk Management in Drug GMP Quality Management System |
| 投稿时间：2016-10-20 |
| DOI：10.16153/j.1002-7777.2018.01.015 |
| 中文关键词: GMP 质量管理体系 变更控制 偏差管理 质量风险管理 |
| 英文关键词: GMP quality management system alternation control deviation management quality risk management |
| 基金项目: |
|
| 摘要点击次数: 1875 |
| 全文下载次数: 1444 |
| 中文摘要: |
| 目的：概述质量管理体系中变更控制、偏差管理、质量风险管理的内容，对药品生产企业完善质量管理体系进行探讨。方法：以某药品生产企业质量管理体系为依据，以《药品生产质量管理规范》与近年来国内发表的文献为指导，进行归纳、总结与分析。结果与结论：药品生产企业应该加强质量管理体系建设，将偏差处理、变更、风险评估放在重要地位，学习先进的理论和方法，提高质量管理水平，最终完善质量管理体系。 |
| 英文摘要: |
| Objective: To summarize the contents of alternation control, deviation management and quality risk management in the quality management system, so as to improve the quality management system in the pharmaceutical production enterprises. Methods: We summarized and analyzed the quality control standards by using the quality management system in one production enterprise as a basis and the guidance of GMP and the literatures published recently in China. Results and Conclusion: The pharmaceutical production enterprises should strengthen the construction of the quality management system, give priority to deviation management, alternation and risk assessment, and learn advanced theory and method, so as to improve the quality management level, and ultimately improve the quality management system. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |